If you view the weekly press release (look to the right side below the top chart for links to the two most recent weekly releases), at the end of the press text you'll see a link to a 'Weekly Rail Traffic Charts' pdf file. That file contains the detailed numbers and y-o-y comparisons by each carload type
Well there you have it. Muslims want to sort out their problems without outside interference.
@@@@Iraqi Shia militias refuse to fight with coalition against ISIS Move by Shia militias poses a dilemma for Western allies such as Canada The U.S.-led coalition engaged in airstrikes against ISIS is locked in a major confrontation with some of its most important de facto allies on the ground. Iraqi Shia militias, which have borne the brunt of the fighting on the ground against the Sunni jihadists of ISIS in central and western Iraq, say they don't want the coalition’s assistance. Some groups are refusing to continue fighting and one has even threatened to shoot down coalition aircraft.
Well it's unfortunate bad you feel that way. I post many of my trades but don;t bother responding to jerks.... that's what ignore is for. Anyway, I went into BTU probably 2 years ago now using leaps calls that I rolled down and out a couple of times (yeah that's how I feel about it too). With a strike at 13 they're worthless now but I viewed coal as a high risk play so kept the total invested amount to a only a few % of my portfolio. I continue to follow BTU and other coal stocks but stopped throwing money at it last fall when it hit 10. Until coal prices see a sustained turn back up I see no reason to buy any shares or options, so am a bit surprised when I see a long-term player like you guys still putting money into this. Anyway, I hope it works out for you, and that you have other successful holdings that have made up for this slow-moving disaster.
---which is why I bought more yesterday and today---
What does your latest share purchase bring your adjusted cost basis down to, if you don't mind me asking?
Unexpected given the good FTV progress and no new technical issues reported
@@@@@Bombardier CSeries delivery pushed to 2016 - report 15 minutes ago by Thomson Reuters TORONTO, March 27 (Reuters) - Bombardier Inc will not deliver its first CSeries jet until 2016, missing a longstanding target, Bloomberg reported on Friday, citing the company's new chief executive. Chief Executive Alain Bellemare said last month that while Bombardier was committed to having the plane certified by the end of 2015, its entry into service could be in 2016 depending on decisions made by customers. Bombardier had long said it was targeting entry into service in the second half of 2015. But in a February filing it shifted its language slightly, saying it expected certification in the second half of 2015, and entry into service "shortly thereafter." (Reporting by Allison Martell; Editing by Chizu Nomiyama)
Well, I'm not a dental surgeon, but I see a few reasons why they might stick with Invisalign even if lower cost alternatives appear.
First there is branding. If customers perceive Invisalign as a superior solution and their insurance plan coverage is decent, they may feel more comfortable to go with the leader and insist on that. I always do research online and ask questions when I go to the dentist's office, and the dentist does not force me into options I don't personally like or approve of.
Second, orthodontists who run a lot of cases where ALGN, due to their advanced IP portfolio, offers the only available solution to some more complex cases, may decide it is simpler to work with one provider rather than splitting up the business across ALGN for the complex cases and a competitor for more basic cases. ALGN could also offer reduced prices on simpler cases to retain the surgeon as a customer for the more complex (and presumably higher margin) cases.
Finally, never underestimate the value of a strong vendor-client relationship. If a surgeon has dealt with ALGN for many years and is satisfied with the sales rep's efforts and the product performance, it may not be so easy for a competitor to displace ALGN through reduced prices alone.
NVO was rangebound (at least on the US exchange anyway) for a year and when it finally breaks out on excellent news you suggest to sell it? I suggest you go do some due diligence about this company first before you blabber such nonsense.
FYI: CLF CEO was not invited to testify.
@@@@@United States Steel Corp. President and CEO Mario Longhi joined steel industry leaders Thursday to ask Congress to change trade policies in order to level the playing field for domestic steel producers.
Not since the late 1990s has the industry faced such a torrent of steel imports, Longhi said, addressing members of the Congressional Steel Caucus. "Total and finished steel products imported into our market by heavily subsidized, command economies increased year-to-year between 22 percent to 90 percent," he said. "The last time we were at these levels, nearly half of American steel companies disappeared. Today, across the country, once again, mills are idled. Plants continue to be shut down. American workers are laid off."
@"play" ARM by buying chip equipment ..."
@anybody understand this ?? anyone ??
I think an analogy would be... if you think the food dining business segment will continue to grow, it's simpler and less risky to invest in a food preparation equipment company like MIDD that sells to the entire industry instead of trying to pick which restaurant chain will dominate.
In a recent SA article, a writer suggested that the patent expiry issue was overblown. I think that with the steady stream of innovations and an established brand, the company will perform reasonably well.
I am, however, a bit concerned with the BOD choice for a new CEO. This guy has good qualifications from his term at GE, but he was unable to turn ABB around (although to be fair, he did have to face big challenges there due to the great recession).
@@@@Concern over pending patent expiration is unjustified as Align is in a good position to outcompete new entrants with its remaining and newly issued patents. Patent Protection: Other firms cannot easily replicate what ALGN does because of 372 U.S. patents and 257 foreign patents, with more pending. Although some patents expire by 2017, leading many to believe ALGN will be open to fierce competition and decline in value, even after expiry competitors will only have available to them older versions of Invisalign since Align has new patents protecting its latest innovations.
Here's the news
@@@@@03/26/2015 | 12:30pm US/Eastern BAGSVAERD, Denmark, March 26, 2015 (GLOBE NEWSWIRE) -- Novo Nordisk today announced that the company has decided to submit the prespecified interim analysis of DEVOTE as part of a Class II Resubmission of the New Drug Applications (NDAs) of Tresiba® and Ryzodeg® to the US Food and Drug Administration (FDA). The resubmission is expected to take place within the next month.
After a year stuck in a trading range 42-49, last week NVO broke through resistance at 49.10. Today it is up strongly on higher than ave volume in a weak market... Is it simply a 'catch up' with the rest of the pharma space or some news pending?